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Important methodological flaws in the
recently published clinical prediction model
the REMEMBER score
Anders Granholm1* , Anders Perner1,2, Aksel Karl Georg Jensen2,3 and Morten Hylander Møller1,2
See related research by Wang et al., https://ccforum.biomedcentral.com/articles/10.1186/s13054-019-2307-y
We have with interest read the recently published paper by
Wang et al. in Critical Care, which proposes a new clinical
prediction model—the REMEMBER score—to predict
in-hospital mortality in patients undergoing venoarterial
extracorporeal membrane oxygenation (VA-ECMO) after
coronary artery bypass grafting [1]. The topic is clinically
relevant; however, the study suffers from important meth-
odological shortcomings, which hamper the validity of the
findings and conclusions presented.
First, the study is critically underpowered. An effective
sample size (minimum number of events or non-events) of
≥ 10 per candidate variable is recommended [2], and often
more are required [3]. This number is 4–5 for the RE-
MEMBER score (74 non-events/17 candidate variables).
Consequently, the risk of random errors, overfitting, and
inflated performance estimates is high. The performance
will almost certainly deteriorate when used in other popula-
tions, and the single-centre design increases this risk.
Second, calibration was only assessed using the Hosmer-
Lemeshow Ĉ test, which is highly sensitive to sample size
and unable to indicate lack of fit when power is low [2]. Lack
of significance for this test does not equal adequate fit, and
calibration plots or regressions of the predicted versus ob-
served outcomes are recommended [2].
Third, comparing a newly developed prediction model
with existing models using the development dataset is
not recommended [2], as this approach is biassed to-
wards favouring the new model, especially when the risk
of overfitting is high. A different cohort independent of
model development must be used [2].
Additional important limitations include the long recruit-
ment period where standards of care may have changed,
the use of a non-fixed-time mortality outcome affected by
discharge practices, the lack of external validation, and the
reporting, which lacks information on sample size consider-
ations and missing data handling, and inadequately ac-
knowledges important limitations [4].
We are worried about the consequences if the REMEMBER
score is used to select patients for VA-ECMO as suggested [1].
VA-ECMO is a costly and highly invasive treatment with se-
vere potential adverse effects, and we agree that research within
this area is highly needed [5]. Prediction models are relevant in
this context; however, it is paramount that such models are de-
veloped, validated, and reported appropriately [2, 4]. If not,
their use may put patients at risk and lead to inappropriate use
of resources. Developing and validating a trustworthy clinical
prediction model in this very selected patient population likely
requires international, multicentre collaboration [5].
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The REMEMBER score was developed according to
the SAVE score [6], ENCOURAGE score [7], and two
published recommendations [8, 9]. Actually, we have
mentioned that the single-centre design and absence of
external validation may limit the generalizability of the
REMEMBER score. Theoretically, the number of pa-
tients included in this study might be a little limited re-
garding the number of variables included in the model,
which is similar in the ENCOURAGE score. Thus, we
performed a bootstrap analysis, and it showed similar
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results, confirming the stability of the original model. In
addition, a post hoc random forest analysis [10] was per-
formed, in which the six pre-ECMO parameters of the
REMEMBER score were the top 10 risk factors. As for
calibration, we also investigated the relationship between
the predicted and observed outcomes grouped by RE-
MEMBER score classes using a method that was similar
to the calibration plots and found that there was a very
good overlap between observed and expected mortality
in all four groups. Calibration regression of the predicted
versus observed outcomes is always recommended for
external validation. Over the last 14 years, our surgical
approach to CABG and standards of care have not chan-
ged much over the last 14 years, and year of ECMO was
not associated with mortality by univariable analysis (p
= 0.698). Given the absence of external validation, we
have moderated the conclusion and did not use con-
firmatory terms in the paper. Prospective studies are
needed to externally validate the scoring system before it
can be widely applied.
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